Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on EquityTimes Interest Earned

Preaxia Health Care Payment Systems (PAXH) Return on Sales (2021 - 2023)

Preaxia Health Care Payment Systems' Return on Sales history spans 3 years, with the latest figure at 6206.93% for Q1 2023.

  • For Q1 2023, Return on Sales fell 553841.0% year-over-year to 6206.93%; the TTM value through Feb 2023 reached 6206.93%, down 593309.0%, while the annual FY2022 figure was 490.88%, 9381.0% down from the prior year.
  • Return on Sales for Q1 2023 was 6206.93% at Preaxia Health Care Payment Systems, down from 1833.97% in the prior quarter.
  • Across five years, Return on Sales topped out at 138.86% in Q2 2021 and bottomed at 6206.93% in Q1 2023.
  • The 3-year median for Return on Sales is 668.51% (2022), against an average of 1413.63%.
  • The largest annual shift saw Return on Sales surged 47335bps in 2022 before it plummeted -553841bps in 2023.
  • A 3-year view of Return on Sales shows it stood at 189.8% in 2021, then plummeted by -866bps to 1833.97% in 2022, then tumbled by -238bps to 6206.93% in 2023.
  • Per Business Quant, the three most recent readings for PAXH's Return on Sales are 6206.93% (Q1 2023), 1833.97% (Q4 2022), and 539.63% (Q3 2022).